Skip to main content
Fig. 10 | BMC Complementary Medicine and Therapies

Fig. 10

From: A network pharmacology approach to decipher the mechanism of total flavonoids from Dracocephalum Moldavica L. in the treatment of cardiovascular diseases

Fig. 10

Effects of TFDM on the expression of NOX-4, PGC-1α, p-P38 MAPK/P38 MAPK and p-Erk1/2/Erk1/2. A Western blotting was performed to detect the expression levels of NOX-4. n = 3, ##P < 0.01 versus the control group, **P < 0.01 versus the model group, *P < 0.05 versus the model group. B Western blotting was performed to detect the expression levels of PGC-1α. n = 3, ####P < 0.0001 versus the control group, ****P < 0.0001 versus the model group, *P < 0.05 versus the model group. C Western blotting was performed to detect the expression levels of p-P38 MAPK and P38 MAPK. n = 3, ##P < 0.01 versus the control group, **P < 0.01 versus the model group, *P < 0.05 versus the model group. D Western blotting was performed to detect the expression levels of p-Erk1/2 and Erk1/2. n = 3, #P < 0.05 versus the control group, ***P < 0.001 versus the model group, **P < 0.01 versus the model group

Back to article page